BRD.F BRASKEM PFD ADR/2 O.N.
- Market cap
- EUR 375M
- P/E
- -
- P/B
- 179.33x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is BRD.F undervalued?
Graham numberThe Graham number of BRASKEM PFD ADR/2 O.N. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BRASKEM PFD ADR/2 O.N. fundamental analysis
No fundamental analysis for BRASKEM PFD ADR/2 O.N. yet.
BRASKEM PFD ADR/2 O.N. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About BRASKEM PFD ADR/2 O.N.
Braskem S.A., together with its subsidiaries, engages in the manufacture, sale, import, and export of chemicals, petrochemicals, and fuels in Brazil. The company supplies electricity and other inputs to second-generation producers; sells utilities, such as steam, water, compressed air and industrial gases; industrial services; and engages in the production, supply, and sale of electric energy and gas. It also produces and sells polyethylene, including the production of green…
Full company profileBRASKEM PFD ADR/2 O.N. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
BRASKEM PFD ADR/2 O.N. annual financial statements (BRL; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 106B | 96.5B | 70.6B | 77.4B | 70.7B | 74.4B |
| Gross Profit | 32.1B | 11.4B | 3.02B | 6.00B | 1.56B | 12.8B |
| Operating Income | 27.2B | 6.11B | -1.75B | -990M | -1.64B | 7.57B |
| EBITDA | - | 8.11B | 3.26B | -7.35B | 7.08B | 18.7B |
| Net Income | 14.0B | -336M | -4.58B | -11.3B | -9.88B | 9.54B |
| EPS | 18 | -0.42 | -5.75 | -14 | -12 | 12 |
| Balance Sheet | ||||||
| Total Assets | 92.6B | 88.0B | 91.7B | 102B | 81.9B | 79.2B |
| Total Liabilities | 86.4B | 81.9B | 88.5B | 106B | 98.4B | 92.3B |
| Shareholders' Equity | 7.87B | 7.32B | 3.99B | -4.78B | -16.1B | -12.6B |
| Cash & Short-term Investments | 8.68B | 12.5B | 14.2B | 15.0B | 10.5B | 3.93B |
| Cash Flow | ||||||
| Operating Cash Flow | 14.8B | 8.95B | -2.27B | 2.44B | -4.20B | -8.44B |
| Capital Expenditure | 3.42B | 4.85B | 4.53B | 3.76B | 3.13B | 2.62B |
| Free Cash Flow | 11.4B | 4.10B | -6.80B | -1.33B | -7.33B | -11.1B |
| Ratios | ||||||
| ROE | 177.8% | -4.6% | -114.7% | - | - | - |
| ROA | 15.1% | -0.4% | -5.0% | -11.1% | -12.1% | 12.0% |
| Net Profit Margin | 13.2% | -0.3% | -6.5% | -14.6% | -14.0% | 12.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
BRASKEM PFD ADR/2 O.N. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Apr 19, 2022
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | BRL 6.00M | 0.01 | - |
| 2023 | BRL 7.00M | 0.01 | - |
| 2022 | BRL 1.35B | 1.70 | - |
| 2021 | BRL 5.99B | 7.53 | 42.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on May 16, 2005.
Who owns BRASKEM PFD ADR/2 O.N.
- Insiders 6.60%
- Institutions 10.10%
- Public & others 83.30%
- Shares outstanding 173M
- Free float 111M
BRASKEM PFD ADR/2 O.N. company profile
- Company name
- BRASKEM PFD ADR/2 O.N.
- Ticker
- BRD.F
- Exchange
- Frankfurt Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 8,233
- Fiscal year end
- December
- Address
- Rua Lemos Monteiro, 120, São Paulo, SP, Brazil, 05501-050
- Phone
- 55 11 3576 9531
- Website
- braskem.com.br
About BRASKEM PFD ADR/2 O.N.
Braskem S.A., together with its subsidiaries, engages in the manufacture, sale, import, and export of chemicals, petrochemicals, and fuels in Brazil. The company supplies electricity and other inputs to second-generation producers; sells utilities, such as steam, water, compressed air and industrial gases; industrial services; and engages in the production, supply, and sale of electric energy and gas. It also produces and sells polyethylene, including the production of green PE made from renewable resources, and polypropylene; and polyvinyl chloride and caustic soda. In addition, the company provides thermoplastic resins; and other basic petrochemicals. It has operations in the United States, Europe, Asia, and internationally. The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002. Braskem S.A. was founded in 1972 and is headquartered in São Paulo, Brazil.
BRASKEM PFD ADR/2 O.N. management
10- Dr. Helcio TokeshiChief Executive Officer
- Mr. Carlos Augusto Machado Pereira de Almeida BrandãoInvestor Relations Officer & CFO · born 1974
- Mr. Raphael Franco de CamposChief Operating Officer
- Mr. João Henrique RittershaussenExecutive Officer and Head of Investments & Digital Technologies · born 1964
- Mr. Alessandro de Castro MeloChief Engineering, Technology & Innovation Officer
- Ms. Camilla Tedeschi de Toledo TapiasGeneral Counsel
- Mr. Márcio PitzerCompliance & Conformity Officer · born 1979
- Mr. Nir LanderVice President of People, Communication & Supply Chain
- Dr. Daniel P. MacEachranHead of Metabolic Engineering
- Mr. Luiz Gustavo Perrotti RossatoChief Transformation Officer · born 1979